As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector ...

Overall, ESMO 2025 reinforced the growing potential of biomarkers in cancer, with AI integration accelerating adoption. As ...

Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research ...

Novartis’ Itvisma (onasemnogene) has been approved by the US FDA to treat spinal muscular atrophy (SMA) in children aged two ...

Regeneron Pharmaceuticals’ Libtayo (cemiplimab) has received approval from the European Commission for the adjuvant treatment ...

Sandoz has announced that Tyruko, the first and only FDA-approved biosimilar for multiple sclerosis (MS), is now available in ...

Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

Over the past six decades, anti-thrombotic drug therapies have undergone a revolution, leading to major improvements in ...

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led ...

SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and ...

The US Food and Drug Administration (FDA) has approved PADCEV (enfortumab), in combination with Keytruda (pembrolizumab) or ...